Clinical Trials on Substance Abuse in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
- Brigham and Womens' Hospital, Center for Surgery and Public Health
- Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
- Australian Childhood Foundation
- Resurge Therapeutics Inc.
- The Depressive and Bipolar Disorder Alternative Treatment Foundation
- Zhijun Sun
- Sonogenix
- Carlos III Health Institute
- Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
- Paul W. Read, MD
- Sociedad Española de Arteriosclerosis
- Epicentre, Paris, France.
- Kettering Foundation
- Health Holding Company, Hail Health Cluster, Saudi Arabia
- wenbinlu
- Laboratoires Iprad-Vegebom
- Remedy Institute
- Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
- NATURAmedicatrix Sàrl
- Prader-Willi Syndrome Association of Australia
- View Full List
Medical Conditions
- Intervention Studies
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Psychoactive Substance Use
- Stage III Childhood Anaplastic Large Cell Lymphoma
- Adherence to In-Office Glaucoma Evaluation Appointment
- Malignant Tumor of Extrahepatic Bile Duct
- Refractory B-Lineage Lymphoma
- Stage IIIB Esophageal Adenocarcinoma
- Stroke Recrudescence
- Hernia,Ventral
- Marginal Zone B-cell Lymphoma
- Spinocerebellar Ataxia Genotype Type 3
- Cell Senescence
- Escape Room Games and Role Playing Gamification
- Pregnancy; Accident
- Neurobehavioral Manifestation
- Ankle Trauma
- Mycobacterium Avium Complex Infections
- Lymphoblastic Lymphoma
- Apneic; Oxygenation
- View Full List
Drug Interventions
- Low molecular weight Heparin as standard of care treatment
- Lansoprazole 15mg QD
- Fostamatinib
- ART-123
- Oral Aztreonam
- Omeprazole 40 mg
- SBI-087
- Fenofibric acid 135mg
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- Everolimus
- Optiva artificial tear by Allergan
- LINjeta U-100 Insulin
- Colecalciferol D3 (Vigantol Oil)
- FRSW107
- Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
- Epalrestat
- Gadoteridol (ProHance)
- 300 mg of caffeine citrate infusion
- Triple therapy
- Irinotecan
- View Full List
CROs by country
- Contract Research Organizations in Burundi
- Contract Research Organizations in Chile
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Malawi
- Contract Research Organizations in Mali
- Contract Research Organizations in Portugal
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Suriname
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Togo
- Contract Research Organizations in Venezuela
- CRO list by country